• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯尼达明与β-环糊精或羟丙基-β-环糊精之间的相互作用。

Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.

作者信息

Palmieri G F, Wehrlé P, Martelli S

机构信息

Dipartimento di Scienze Chimiche, Università di Camerino, Italy.

出版信息

Drug Dev Ind Pharm. 1998 Jul;24(7):653-60. doi: 10.3109/03639049809082367.

DOI:10.3109/03639049809082367
PMID:9876510
Abstract

The possibility of obtaining inclusion complexes between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin have been evaluated by phase solubility diagram, differential scanning calorimetry (DSC), and x-ray diffractometry. The applied complexation methods were spray-drying, kneading, and solid dispersion. DSC and x-ray analyses of the powders revealed an external interaction between lonidamine and cyclodextrins. Dissolution profiles of the obtained powders were also studied to define the most appropriate preparation method and molar ratio to use in attempts to increase lonidamine water solubility.

摘要

已通过相溶解度图、差示扫描量热法(DSC)和X射线衍射法评估了氯尼达明与β-或羟丙基-β-环糊精之间形成包合物的可能性。应用的络合方法有喷雾干燥、捏合和固体分散。对粉末进行的DSC和X射线分析显示氯尼达明与环糊精之间存在外部相互作用。还研究了所得粉末的溶出曲线,以确定在试图提高氯尼达明水溶性时最适合的制备方法和摩尔比。

相似文献

1
Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.氯尼达明与β-环糊精或羟丙基-β-环糊精之间的相互作用。
Drug Dev Ind Pharm. 1998 Jul;24(7):653-60. doi: 10.3109/03639049809082367.
2
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
3
In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.采用冷冻干燥法制备的戊巴比妥/羟丙基-β-环糊精复合物的体外和体内评价
Pharmazie. 2000 Jul;55(7):513-7.
4
Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.通过与β-环糊精络合改善呋塞米的溶解性能。
Drug Dev Ind Pharm. 1998 Jan;24(1):19-25. doi: 10.3109/03639049809082348.
5
Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.为改善除草剂配方制备并表征去草净与β-环糊精的包合物
J Agric Food Chem. 2004 Feb 25;52(4):864-9. doi: 10.1021/jf0350358.
6
Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.采用超临界抗溶剂(SAS)法制备辛伐他汀/羟丙基-β-环糊精包合物及其表征
Eur J Pharm Biopharm. 2007 Jun;66(3):413-21. doi: 10.1016/j.ejpb.2006.11.013. Epub 2006 Nov 29.
7
Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.通过差示扫描量热法(DSC)、傅里叶变换红外光谱法(FT-IR)、X射线衍射法和扫描电子显微镜(SEM)分析对冻干槲皮素-环糊精二元体系进行研究。
J Pharm Biomed Anal. 2004 Feb 4;34(2):333-9. doi: 10.1016/S0731-7085(03)00529-6.
8
Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.华法林-β-环糊精包合物的处方前研究
Int J Pharm. 2005 Mar 3;291(1-2):3-10. doi: 10.1016/j.ijpharm.2004.11.013. Epub 2004 Dec 28.
9
Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.卤泛群-2-羟丙基-β-环糊精二元体系的溶出特性及表征
Pharmazie. 2007 Nov;62(11):858-63.
10
Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.奥美拉唑与天然及化学修饰β-环糊精包合物的固态表征及溶出曲线
Eur J Pharm Biopharm. 2007 Sep;67(2):531-9. doi: 10.1016/j.ejpb.2007.03.005. Epub 2007 Mar 13.